⌘K
Loading ticker…
Balchem Corporation · Healthcare · Chemicals
As of 2026-06-26, Balchem Corporation (BCPC) has a 3-month relative strength percentile of 46 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.1%, relative volume 3.28×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
46 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BCPC is in a stage 3 topping pattern, week 1. Currently in a 81-day base; basing ADR 2.3% (broad 2.4%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 4.1% / 5.7%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
BCPC is held by 8 ETFs as of Mar 2026. Top owner: IJR at 0.36% weight, $330M notional. Top 3 carry $637M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.36% | $330M |
| VTIVanguard Total Stock Market ETF | 0.01% | $172M |
| IWMiShares Russell 2000 ETF | 0.19% | $135M |
| VBVanguard Small Cap ETF | 0.08% | $125M |
| VBKVanguard Small-Cap Growth ETF | 0.18% | $70M |
| VXFVanguard Extended Market ETF | 0.08% | $61M |
| IWOiShares Russell 2000 Growth ETF | 0.37% | $45M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $7M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BCPC Jan avg: 2.57% median: 2.56% win: 50% σ: 7.73% n: 4 2022-04-12 → 2026-05-29 | BCPC Feb avg: 6.77% median: 7.71% win: 75% σ: 5.34% n: 4 2022-04-12 → 2026-05-29 | BCPC Mar avg: -3.83% median: -3.66% win: 0% σ: 2.25% n: 4 2022-04-12 → 2026-05-29 | BCPC Apr avg: -4.61% median: -5.69% win: 20% σ: 5.03% n: 5 2022-04-12 → 2026-05-29 | BCPC May avg: 1.44% median: 1.00% win: 60% σ: 6.16% n: 5 2022-04-12 → 2026-05-29 | BCPC Jun avg: 2.26% median: 2.25% win: 75% σ: 5.77% n: 4 2022-04-12 → 2026-05-29 (current) | BCPC Jul avg: 3.91% median: 2.29% win: 50% σ: 8.40% n: 4 2022-04-12 → 2026-05-29 | BCPC Aug avg: 1.86% median: 2.02% win: 50% σ: 4.19% n: 4 2022-04-12 → 2026-05-29 | BCPC Sep avg: -6.87% median: -7.60% win: 0% σ: 4.62% n: 4 2022-04-12 → 2026-05-29 | BCPC Oct avg: 1.50% median: -1.35% win: 50% σ: 9.74% n: 4 2022-04-12 → 2026-05-29 | BCPC Nov avg: 4.43% median: 4.57% win: 100% σ: 3.68% n: 4 2022-04-12 → 2026-05-29 | BCPC Dec avg: -1.39% median: -5.77% win: 25% σ: 14.57% n: 4 2022-04-12 → 2026-05-29 |